{ "id": "eph5tzz79k", "slug": "reverse-phase-protein-array", "title": "Reverse phase protein array", "updated": "2026-10-15", "topic_path": [ { "id": "life", "label": "Life and health", "api_url": "https://www.edgepedia.org/api/v1/topics/life" }, { "id": "life.biology", "label": "Biological foundations", "api_url": "https://www.edgepedia.org/api/v1/topics/life.biology" }, { "id": "life.biology.biochemistry", "label": "Biochemistry and metabolism", "api_url": "https://www.edgepedia.org/api/v1/topics/life.biology.biochemistry" }, { "id": "life.biology.biochemistry.practice", "label": "Biochemistry field and methods", "api_url": "https://www.edgepedia.org/api/v1/topics/life.biology.biochemistry.practice" }, { "id": "life.biology.biochemistry.practice.methods", "label": "Biochemical methods and techniques", "api_url": "https://www.edgepedia.org/api/v1/topics/life.biology.biochemistry.practice.methods" }, { "id": "life.biology.biochemistry.practice.methods.assays", "label": "Assay techniques", "api_url": "https://www.edgepedia.org/api/v1/topics/life.biology.biochemistry.practice.methods.assays" } ], "geo": [ { "id": "geo.nongeo.t1946.life.biology.biochemistry.practice.methods.assays", "label": "Non-geographic · 1946 to 2000: Assay techniques", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.biology.biochemistry.practice.methods.assays", "path": [ { "id": "geo.nongeo", "label": "Non-geographic", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo" }, { "id": "geo.nongeo.t1946", "label": "Non-geographic · 1946 to 2000", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946" }, { "id": "geo.nongeo.t1946.life", "label": "Life and health", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life" }, { "id": "geo.nongeo.t1946.life.biology", "label": "Biological foundations", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.biology" }, { "id": "geo.nongeo.t1946.life.biology.biochemistry", "label": "Biochemistry and metabolism", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.biology.biochemistry" }, { "id": "geo.nongeo.t1946.life.biology.biochemistry.practice", "label": "Biochemistry field and methods", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.biology.biochemistry.practice" }, { "id": "geo.nongeo.t1946.life.biology.biochemistry.practice.methods", "label": "Biochemical methods and techniques", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.biology.biochemistry.practice.methods" }, { "id": "geo.nongeo.t1946.life.biology.biochemistry.practice.methods.assays", "label": "Assay techniques", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.biology.biochemistry.practice.methods.assays" } ] } ], "excerpt": "Reverse phase protein array (RPPA) is a targeted proteomics method that spots many samples as microdots on slides and probes them one antibody at a time.", "snippet": "Reverse phase protein array (RPPA) is a targeted proteomics method that spots many samples as microdots on slides and probes them one antibody at a time.", "node": "life.biology.biochemistry.practice.methods.assays", "markdown": "# Reverse phase protein array\n\nReverse phase protein array (RPPA) is a targeted proteomics method in which lysates from many samples are spotted as microdots onto nitrocellulose-coated slides and probed one antibody at a time, quantifying total protein abundance and post-translational modification states, especially phosphorylation, across hundreds to thousands of samples.[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC7861052/) The platform measures both total protein and specific modifications such as phosphorylation, methylation, and acetylation, depending on the antibody used.[2](https://link.springer.com/protocol/10.1007/978-1-0716-4595-6_5)\n\n| Key fact | Value |\n|---|---|\n| Format | Whole lysate spotted on nitrocellulose; one antibody per slide[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC7861052/) |\n| Slide capacity | Up to 1,056 samples plus 96 controls in 5-step 2-fold dilution series[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC5111873/) |\n| Sample need | 40 µl suffices for 150 antibodies[4](https://tcpa.drbioright.org/rppa500/faq.html) |\n| Target count | Roughly 130–300 validated antibodies per platform[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC5111873/) • [4](https://tcpa.drbioright.org/rppa500/faq.html) |\n| Sensitivity | Picomole-to-femtomole range, precision <15% CV[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC4083105/) |\n| Throughput | 240 antibodies labeled and scanned in 11–13 days[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC7861052/) |\n| Introduced | Paweletz and colleagues, Oncogene, 2001[6](https://doi.org/10.1038/sj.onc.1204265) |\n\n## How it works\n\nIn the reverse-phase configuration, the analytes themselves are immobilized on the solid phase, usually nitrocellulose, and each slide is then probed with a single antibody or other affinity reagent against one target.[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC4083105/) This is the opposite of forward-phase or antibody-capture arrays, in which multiple antibodies are immobilized on the surface to capture proteins from a sample.[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC2981612/) Because every sample occupies only a microspot, one slide carries hundreds of samples and is read with one antibody.[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC5111873/)\n\n[Serial dilution](https://www.edgepedia.org/serial-dilution) is the quantification trick: each sample is printed as a dilution series, typically five 2-fold steps, so that at least one dilution of every sample falls within the antibody's linear response range.[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC5111873/) Fitting a curve through the dilution series converts raw spot intensities into a single relative concentration per sample.[8](https://pmc.ncbi.nlm.nih.gov/articles/PMC2647837/)\n\n## How it is done\n\nA typical workflow runs as follows. Lysates are prepared in SDS-containing buffer with protease and phosphatase inhibitors; one protocol recommends 1 ml buffer per 40 mg tissue or \\( 3 \\times 10^{6} \\) cells.[9](https://gracebio.com/wp-content/uploads/2017/04/User_Guide_Reverse_Phase_Protein_Array_Assay_System_Rev_0.pdf) Samples are serially diluted, usually five 2-fold steps, and robotically spotted in triplicate on nitrocellulose-coated slides with an Aushon 2470 arrayer; each spot transfers nanoliters of lysate.[10](https://pmc.ncbi.nlm.nih.gov/articles/PMC4213190/) • [11](https://bcmd8.bcm.edu/academic-centers/dan-l-duncan-comprehensive-cancer-center/research/cancer-center-shared-resources/antibody-based-proteomics/protocols-workflow) • [12](https://aacrjournals.org/mct/article/5/10/2512/234818/Reverse-phase-protein-array-validation-of-a-novel) Slides are blocked and probed with one primary antibody, followed by biotinyl-tyramide signal amplification with HRP and DAB or IRDye detection, then scanned and quantified with software such as Array-Pro Analyzer or GenePix.[10](https://pmc.ncbi.nlm.nih.gov/articles/PMC4213190/) • [1](https://pmc.ncbi.nlm.nih.gov/articles/PMC7861052/)\n\nNormalization corrects for total protein loaded; the Baylor core computes \\( N = (A - C)/T \\cdot M \\), where A is raw antibody signal, C the negative-control signal, T the total protein signal, and M the group median.[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC4083105/) • [11](https://bcmd8.bcm.edu/academic-centers/dan-l-duncan-comprehensive-cancer-center/research/cancer-center-shared-resources/antibody-based-proteomics/protocols-workflow) [Housekeeping](https://www.edgepedia.org/housekeeping) proteins such as β-actin have also been used to normalize RPPA data, though such proteins are themselves subject to biological regulation.[13](https://www.mdpi.com/2076-3905/4/4/520) Standard quality controls include a mixed control lysate serially diluted over a range of 0.0078 mg/ml to 1 mg/ml to test the linear range of antibody response.[11](https://bcmd8.bcm.edu/academic-centers/dan-l-duncan-comprehensive-cancer-center/research/cancer-center-shared-resources/antibody-based-proteomics/protocols-workflow)\n\n## Origin\n\nThe term \"reverse phase protein microarray\" was coined by Cloud P. Paweletz and colleagues in a 2001 Oncogene paper applying the technology to laser capture microdissected pre-malignant prostate lesions; that study showed activation of pro-survival pathways at the cancer invasion front.[6](https://doi.org/10.1038/sj.onc.1204265) • [5](https://pmc.ncbi.nlm.nih.gov/articles/PMC4083105/) • [13](https://www.mdpi.com/2076-3905/4/4/520) The method is a direct descendant of miniaturized immunoassays.[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC2981612/) Satoshi Nishizuka and colleagues then built higher-density arrays profiling the NCI-60 cell lines in 2003,[14](https://doi.org/10.1073/pnas.2331323100) Steven M. Chan and colleagues reported a multiplexed protein microarray platform for analysis of signal transduction pathways in 2004,[15](https://doi.org/10.1038/nm1139) and Raoul Tibes and colleagues validated the technology for primary leukemia specimens and hematopoietic stem cells in 2006.[16](https://doi.org/10.1158/1535-7163.mct-06-0334)\n\n## Variants\n\nDetection chemistry varies by center: colorimetric DAB read on flatbed scanners, chemiluminescence, near-infrared fluorescent dyes, and tyramide-amplified fluorescence. Fluorescence offers a large dynamic range but suffers photobleaching; chemiluminescence is sensitive but time-dependent, complicating cross-study comparison.[17](https://www.mdpi.com/2076-3905/4/2/98) • [13](https://www.mdpi.com/2076-3905/4/4/520) The commercial Zeptosens platform uses planar waveguide fluorescence reaching zeptomole detection limits.[18](https://link.springer.com/article/10.1186/s12967-024-05616-7) • [19](https://doi.org/10.1007/978-981-32-9755-5_3) Analysis software variants include SuperCurve, the serial dilution curve method of [Li Zhang](https://www.edgepedia.org/li-zhang) and colleagues, NormaCurve, and RPPA SPACE, which runs up to about 8 times faster than SuperCurve.[8](https://pmc.ncbi.nlm.nih.gov/articles/PMC2647837/) • [20](https://doi.org/10.1093/bioinformatics/btn663) • [21](https://doi.org/10.1007/978-981-32-9755-5_5) • [22](https://pmc.ncbi.nlm.nih.gov/articles/PMC9665860/)\n\n## Applications\n\nRPPA has graduated from research tool to clinical-trial use with clinical-grade sensitivity and precision, serving pharmacodynamic monitoring of targeted agents and biomarker discovery.[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC2981612/) • [3](https://pmc.ncbi.nlm.nih.gov/articles/PMC5111873/) A 2022 report stated that SuperCurve had been applied to over 170,000 samples.[22](https://pmc.ncbi.nlm.nih.gov/articles/PMC9665860/) In serum, RPPA measured [CA19-9](https://www.edgepedia.org/ca19-9) with strong ELISA concordance (r = 0.87; AUC 0.87 versus 0.86) using ≤5 nl per sample instead of ~50 µl per ELISA test.[23](https://pmc.ncbi.nlm.nih.gov/articles/PMC2992687/) A 2024 Nature Cancer atlas expanded RPPA data to approximately 8,000 TCGA samples and around 900 CCLE cell lines covering 447 proteins, with a protein-centered synthetic-lethality strategy validated for protein kinase A subunit α and EGFR.[24](https://www.nature.com/articles/s43018-024-00817-x) In 2025, laser microdissection enrichment coupled to CLIA-grade RPPA entered molecular tumor board workflows with a median dwell time of nine days, supporting additional or alternative therapeutic considerations for 54% of profiled patients; that panel quantified 32 proteins and phosphoproteins from a minimum of 5 µg protein.[25](https://www.nature.com/articles/s41698-025-00868-y) The ZeptoCTC workflow extended RPPA to single circulating tumor cells in 2024,[18](https://link.springer.com/article/10.1186/s12967-024-05616-7) and the CellRPPA computational approach predicts apoptosis cascade expression from H&E-stained images paired with RPPA data.[26](https://journals.plos.org/ploscompbiol/article/file?id=10.1371%2Fjournal.pcbi.1014262&type=printable)\n\n## Limitations and alternatives\n\nRPPA is a profiling immunoassay with pre-specified targets, not a discovery platform like mass spectrometry.[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC4083105/) It depends on antibodies that meet the specificity demands of RPPA, and commercially available antibodies often do not.[17](https://www.mdpi.com/2076-3905/4/2/98) In one screen, 56 antibodies against 48 proteins were deemed suitable for RPPA.[27](https://www.nature.com/articles/s41598-026-48754-2) Validation requires explainable [Western blot](https://www.edgepedia.org/western-blot) bands plus an RPPA–Western correlation of \\( R \\geq 0.7 \\).[28](https://link.springer.com/article/10.1007/s12014-010-9055-y) Batch effects between spotting runs occur and require run-level normalization.[27](https://www.nature.com/articles/s41598-026-48754-2) RPPA and LC-MS are not analytically equivalent: RPPA measures an antibody-recognized epitope, whereas LC-MS infers abundance from digested peptides.[27](https://www.nature.com/articles/s41598-026-48754-2) Compared with Western blotting, RPPA needs nanoliters of lysate rather than protein from \\( 5 \\times 10^{5} \\) cells and is far higher throughput.[12](https://aacrjournals.org/mct/article/5/10/2512/234818/Reverse-phase-protein-array-validation-of-a-novel)\n\n## References\n\n1. [Reverse-Phase Protein Array: Technology, Application, Data Processing, and Integration (J Biomol Tech, 2021)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7861052/)\n2. [High-Throughput Post-Translational Modification Analyses by Reverse Phase Protein Array (Methods in Molecular Biology, Springer, 2025)](https://link.springer.com/protocol/10.1007/978-1-0716-4595-6_5)\n3. [Using Reverse-Phase Protein Arrays (RPPAs) as Pharmacodynamic Assays for Functional Proteomics, Biomarker Discovery, and Drug Development in Cancer (Cancer J, 2016)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5111873/)\n4. [TCPA: FAQ (The Cancer Proteome Atlas)](https://tcpa.drbioright.org/rppa500/faq.html)\n5. [Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report (Mol Cell Proteomics, 2014)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4083105/)\n6. [Cloud P Paweletz and colleagues (2001). Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene.](https://doi.org/10.1038/sj.onc.1204265)\n7. [Reverse phase protein microarrays advance to use in clinical trials (Mol Oncol / Proteomics Clin Appl, 2010)](https://pmc.ncbi.nlm.nih.gov/articles/PMC2981612/)\n8. [Serial dilution curve: a new method for analysis of reverse phase protein array data (Bioinformatics; Zhang et al.)](https://pmc.ncbi.nlm.nih.gov/articles/PMC2647837/)\n9. [Reverse Phase Protein Array Assay System User Guide (Grace Bio-Labs)](https://gracebio.com/wp-content/uploads/2017/04/User_Guide_Reverse_Phase_Protein_Array_Assay_System_Rev_0.pdf)\n10. [A Comprehensive Comparison of Normalization Methods for Loading Control and Variance Stabilization of Reverse-Phase Protein Array Data (Cancer Informatics, 2014)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4213190/)\n11. [Reverse Phase Protein Array Protocols & Workflow (Baylor College of Medicine core facility)](https://bcmd8.bcm.edu/academic-centers/dan-l-duncan-comprehensive-cancer-center/research/cancer-center-shared-resources/antibody-based-proteomics/protocols-workflow)\n12. [Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells (Mol Cancer Ther, 2006; Tibes et al.)](https://aacrjournals.org/mct/article/5/10/2512/234818/Reverse-phase-protein-array-validation-of-a-novel)\n13. [Analysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker Discovery (Microarrays, 2015)](https://www.mdpi.com/2076-3905/4/4/520)\n14. [Satoshi Nishizuka and colleagues (2003). Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proceedings of the National Academy of Sciences.](https://doi.org/10.1073/pnas.2331323100)\n15. [Steven M Chan and colleagues (2004). Protein microarrays for multiplex analysis of signal transduction pathways. Nature Medicine.](https://doi.org/10.1038/nm1139)\n16. [Raoul Tibes and colleagues (2006). Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Molecular Cancer Therapeutics.](https://doi.org/10.1158/1535-7163.mct-06-0334)\n17. [Reverse Phase Protein Arrays, Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical Use (Diagnostics, 2015)](https://www.mdpi.com/2076-3905/4/2/98)\n18. [Miniaturized protein profiling permits targeted signaling pathway analysis in individual circulating tumor cells (J Transl Med, 2024; ZeptoCTC)](https://link.springer.com/article/10.1186/s12967-024-05616-7)\n19. [Gerhard M. Kresbach, Michael Pawlak (2019). High Precision RPPA: Concept, Features, and Application Performance of the Integrated Zeptosens Platform. Advances in experimental medicine and biology.](https://doi.org/10.1007/978-981-32-9755-5_3)\n20. [Li Zhang and colleagues (2009). Serial dilution curve: a new method for analysis of reverse phase protein array data. Bioinformatics.](https://doi.org/10.1093/bioinformatics/btn663)\n21. [Bérengère Ouine and colleagues (2019). Analytical Platforms 1: Use of Cultured Cells and Fluorescent Read-Out Coupled to NormaCurve Normalization in RPPA. Advances in experimental medicine and biology.](https://doi.org/10.1007/978-981-32-9755-5_5)\n22. [RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array data (Bioinformatics, 2022)](https://pmc.ncbi.nlm.nih.gov/articles/PMC9665860/)\n23. [Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer (2010)](https://pmc.ncbi.nlm.nih.gov/articles/PMC2992687/)\n24. [A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies (Nature Cancer, 2024)](https://www.nature.com/articles/s43018-024-00817-x)\n25. [Real-time functional proteomics enhances therapeutic targeting in precision oncology molecular tumor boards (npj Precision Oncology, 2025)](https://www.nature.com/articles/s41698-025-00868-y)\n26. [Predicting protein cascade expression from H&E images (CellRPPA) (PLOS Computational Biology)](https://journals.plos.org/ploscompbiol/article/file?id=10.1371%2Fjournal.pcbi.1014262&type=printable)\n27. [Comparative analysis and correlation of cancer hotspot proteins and cell markers in tumor-normal adjacent breast and kidney samples using RPPA and LC-MS (Scientific Reports, 2026)](https://www.nature.com/articles/s41598-026-48754-2)\n28. [A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers (Clinical Proteomics, 2010)](https://link.springer.com/article/10.1007/s12014-010-9055-y)\n\n---\n*Topic: Encyclopedia › Life and health › Biological foundations › Biochemistry and metabolism › Biochemistry field and methods › Biochemical methods and techniques › Assay techniques*\n\n*Initially written Sep 29, 2026 · Edited: Oct 15, 2026*\n\n*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*\n\nLicense: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license\n", "same_as": [], "url": "https://www.edgepedia.org/reverse-phase-protein-array", "markdown_url": "https://www.edgepedia.org/reverse-phase-protein-array.md", "license": { "name": "Edgepedia Community License 1.0", "url": "https://www.edgepedia.org/edgepedia/license", "summary": "Free with credit, commercial use included. AI training is open to everyone. For other uses, organizations over USD 100M in revenue or 100M monthly users license separately.", "spdx": "LicenseRef-Edgepedia-Community-1.0" }, "credit": "\"Reverse phase protein array\", Edgepedia (EdgeChat), https://www.edgepedia.org/reverse-phase-protein-array. Edgepedia Community License 1.0.", "credit_md": "\"[Reverse phase protein array](https://www.edgepedia.org/reverse-phase-protein-array)\", Edgepedia (EdgeChat), [https://www.edgepedia.org/reverse-phase-protein-array](https://www.edgepedia.org/reverse-phase-protein-array). [Edgepedia Community License 1.0](https://www.edgepedia.org/edgepedia/license).", "credit_html": "\"Reverse phase protein array\", Edgepedia (EdgeChat), https://www.edgepedia.org/reverse-phase-protein-array. Edgepedia Community License 1.0.", "speakable": "Reverse phase protein array is a targeted proteomics method that spots many samples as microdots on slides and probes them one antibody at a time." }